4 completed, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Monophenol Monooxygenase: new trials by email Literature Review of Monophenol Monooxygenase trials Research Report on Monophenol Monooxygenase
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dendritic Cell Vaccination During Lymphoid Reconstruction Autologous Dendritic Cells (DC), Fludarabine, Autologous Lymphocyte Infusion (ALI) - Intraocular Melanoma, Melanoma (Skin) | Phase 1 | Completed | H. Lee Moffitt Cancer Center and Research Institute | 18 | 2006-02-01 | 2014-02-21 |
| Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma ipilimumab, Tyrosinase/gp100/MART-1 Peptides - Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Completed | Bristol-Myers Squibb | 77 | 2004-05-31 | 2022-04-14 |
| Multiepitope Peptide Vaccination in Melanoma Tyrosinase, MAGE-3, GnTV - Metastatic Melanoma | Phase 2 | Unknown | Charite University, Berlin, Germany | 25 | 2003-03-01 | 2010-05-26 |
| Novel Adjuvants for Peptide-Based Melanoma Vaccines MDX-CTLA4 Antibody; Tyrosinase/gp100/MART-1 Peptides Melanoma Vaccine - Melanoma | Phase 1 | Completed | University of Southern California | 19 | 2001-08-01 | 2014-05-22 |
| Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase Immunodominant peptides from three melanoma antigens, MART-1, GP100 and tyrosinase - Melanoma, Neoplasm Metastasis | Phase 2 | Completed | National Cancer Institute (NCI) | 114 | 1997-11-01 | 2008-03-04 |
Melanoma (5) · Neoplasms (2) · Uveal Melanoma (2) · Diabetes Mellitus, Insulin-Dependent, 12 (1) · Neoplasm Metastasis (1)
Bristol-Myers Squibb (1) · Charite University, Berlin, Germany (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · National Cancer Institute (NCI) (1) · University of Southern California (1)
United States (4) · Germany (1)
Jeffrey S. Weber, M.D., Ph.D. (2) · Ulrich Keilholz, MD (1)
P30CA014089 (1), P30CA076292 (1)